Suchergebnisse - "Barlesi, F"

PubPharm (258)

131

Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts

enthalten in: Annals of oncology | 2012

von Reck, M. | Barlesi, F. | Crinò, L. | +4

132

Role of FDG-PET scanning in stage IIIAN2 non-small cell lung cancer

enthalten in: Revue des maladies respiratoires | 2012

von Colavolpe, C. | Bonardel, G. | Guedj, E. | +3

CommentIn: Rev Mal Respir. 2012 Feb;29(2):116-7. - PMID 22405106

133

Second-line treatment of metastatic non-small cell lung carcinoma : What are the options today? What are the perspectives for tomorrow?

enthalten in: Revue des maladies respiratoires | 2012

von Greillier, L. | Barlesi, F.

134

Editorials - Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?

enthalten in: Revue des maladies respiratoires | 2012

von Greillier, L. | Barlesi, F.

135

Role of FDG-PET scanning in stage IIIAN2 non-small cell lung cancer

enthalten in: Revue des maladies respiratoires | 2012

von Colavolpe, C. | Bonardel, G. | Guedj, E. | +3

136

Caring for pain in oncology: Intensify caution in the elderly

enthalten in: Revue des maladies respiratoires | 2012

von Crétel, E. | Bonin-Guillaume, S. | Villani, P. | +1

137

Anti-angiogenic factors in thoracic oncology : successes, failures and prospects

enthalten in: Revue des maladies respiratoires | 2011

von Marco, S. | Tomasini, P. | Greillier, L. | +1

138

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases : a multicenter phase II trial (GFPC 07-01)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Barlesi, F. | Gervais, R. | Lena, H. | +7

139

PCN42 Treatment Costs of Bone Metastases in Patients with Lung Cancer: Results From A French Prospective, Observational, Multicenter Study (GFPC 0601)

enthalten in: Value in health | 2011

von Borget, I. | Decroisette, C. | David, P. | +7

140

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

enthalten in: Annals of oncology | 2011

von Barlesi, F. | Gervais, R. | Lena, H. | +7